State NC
Clinical Trials in North Carolina
Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in North Carolina
Frequently Asked Questions — Clinical Trials in North Carolina
How many clinical trials are currently recruiting in North Carolina?
ClinicalMetric currently tracks 396 actively recruiting clinical trials with at least one location in North Carolina. The total number of registered studies—including active but not currently enrolling trials—is 396. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in North Carolina?
North Carolina hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout North Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in North Carolina?
To join a clinical trial in North Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in North Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in North Carolina
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT03295981 Phase 3
Recruiting
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of ...
Condition
Giant Cell Tumor of Bone
Enrollment
120 pts
Location
United States, Canada, India
Sponsor
St. Louis University
NCT06658730 N/A
Recruiting
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With A...
Condition
Vascular Disease
Enrollment
1,500 pts
Location
United States, Denmark, France
Sponsor
W.L.Gore & Associates
NCT04777357 Phase 3
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Carip...
Condition
Depression
Enrollment
380 pts
Location
United States, Puerto Rico, Russia
Sponsor
AbbVie
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
NCT06084234 Phase 4
Recruiting
National Liver Cancer Screening Trial
Condition
Carcinoma, Hepatocellular
Enrollment
5,500 pts
Location
United States
Sponsor
University of Texas Southweste
NCT06455475 N/A
Recruiting
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care...
Condition
Diabetic Foot Ulcer
Enrollment
150 pts
Location
United States
Sponsor
Capsicure, LLC
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
NCT06150781 N/A
Recruiting
Aimovig Pregnancy Exposure Registry
Condition
Migraine
Enrollment
2,842 pts
Location
United States
Sponsor
Amgen
NCT04667585 N/A
Recruiting
Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx
Condition
Oropharynx Cancer
Enrollment
120 pts
Location
United States
Sponsor
Duke University
NCT04775485 Phase 2
Recruiting
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With R...
Condition
Low-grade Glioma
Enrollment
141 pts
Location
United States, Australia, Canada
Sponsor
Day One Biopharmaceuticals, In
NCT07581899 N/A
Recruiting
Mind Your Heart Intervention for American Indian Women
Condition
Cardiovascular Health
Enrollment
70 pts
Location
United States
Sponsor
University of North Carolina,
NCT06496620 Phase 2
Recruiting
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Condition
COPD
Enrollment
171 pts
Location
United States, Australia, Canada
Sponsor
Uniquity One (UNI)
NCT05797610 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Partici...
Condition
Primary IgA Nephropathy
Enrollment
428 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT05327114 Phase 2, Phase 3
Recruiting
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory De...
Condition
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Enrollment
201 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT07076121 Phase 2, Phase 3
Recruiting
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine ...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06134232 Phase 2
Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + ...
Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Enrollment
400 pts
Location
United States
Sponsor
Dendreon
NCT06544499 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participan...
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
69 pts
Location
United States, Austria, Bulgaria
Sponsor
argenx
NCT04734106 EARLY_Phase 1
Recruiting
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstiti...
Condition
Interstitial Cystitis
Enrollment
30 pts
Location
United States
Sponsor
Wake Forest University Health
NCT05281471 Phase 3
Recruiting
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Phy...
Condition
Platinum-resistant Ovarian Cancer
Enrollment
186 pts
Location
United States
Sponsor
Genelux Corporation
NCT04577599 N/A
Recruiting
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Age...
Condition
Lung Neoplasms
Enrollment
1,160 pts
Location
United States
Sponsor
Wake Forest University Health
NCT05626114 Phase 2
Recruiting
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Acti...
Condition
Geographic Atrophy
Enrollment
60 pts
Location
United States, Israel
Sponsor
Genentech, Inc.
NCT07415044 Phase 2
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Condition
Ulcerative Colitis (UC)
Enrollment
1,431 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT07049926 Phase 1, Phase 2
Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell C...
Condition
Renal Cell Carcinoma
Enrollment
140 pts
Location
United States, Chile, France
Sponsor
Merck Sharp & Dohme LLC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology